<DOC>
	<DOC>NCT01962155</DOC>
	<brief_summary>The aim of our prospective study is to construct and validate a non-invasive model consisting biochemical markers, FibroScan, and radiological parameters for evaluating liver fibrosis caused by hepatitis B virus in mainland China.</brief_summary>
	<brief_title>Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters</brief_title>
	<detailed_description>Up to Oct, 2015,total of 1800 patients with chronic HBV infection were enrolled. Paired blood and liver biopsy samples were collected. Blood samples stored at -80 degree Celsius. Liver biopsy samples were judged by three pathology experts.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>1. HBsAg positive for at least 6 months 2. agree to have liver biopsy 3. Male or female aged 18 to 65 years old 1. Patients with alcoholic liver disease, autoimmune liver disease, heretic liver disease, drug induced liver disease,nonalcoholic liver disease or other chronic liver disease 2. platelet count &lt; 80000/L 3. prothrombin activity â‰¤ 60% 4. patients with any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Fibrosis</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>non-invasive</keyword>
	<keyword>biopsy</keyword>
	<keyword>hepatitis B virus</keyword>
</DOC>